Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes

Pharmacological Research

Volumn 66, Issue 5, 2012, Pages 428-436

  Merighi, Stefania ^a   Gessi, Stefania ^a   Varani, Katia ^a   Fazzi, Debora ^a   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Akt; ERK1 2; Hydrogen sulfide; Keratinocytes; Nitric oxide; VEGF

Indexed keywords

GYY 4137; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHOLIN 4 IUM 4 METHOXYPHENYL(MORPHOLINO)PHOSPHINODITHIOATE; NITRIC OXIDE; PROTEIN KINASE B; SODIUM HYDROSULFIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; HYDROGEN SULFIDE; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORGANOTHIOPHOSPHORUS COMPOUNDS; PROTO-ONCOGENE PROTEINS C-AKT; SULFIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866732949     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.07.002     Document Type: Article

References (51)

1. 2S be the third endogenous gaseous transmitter? FASEB Journal 16 2002 1792 1798
2. P.K. Moore, M. Bhatia, and S. Moochhala Hydrogen sulfide: from the smell of the past to the gas of the future? Trends in Pharmacological Sciences 24 2003 609 611
3. K.R. Olson The therapeutic potential of hydrogen sulfide: separating hype from hope American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 301 2011 R297 R312
4. L. Li, P. Rose, and P.K. Moore Hydrogen sulfide and cell signaling Annual Review of Pharmacology and Toxicology 51 2011 169 187
5. L. Li, and P.K. Moore Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air Trends in Pharmacological Sciences 29 2008 84 90
6. J.L. Wallace, J. Ferraz, and M. Muscara Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury Antioxidants and Redox Signalling 17 2012 58 67
7. L. Li, A. Hsu, and P.K. Moore Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases! Pharmacology and Therapeutics 123 2009 386 400
8. C. Szabó, and A. Papapetropoulos Hydrogen sulphide and angiogenesis: mechanisms and applications British Journal of Pharmacology 164 2011 853 865
9. M. Whiteman, and P.G. Winyard Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising Expert Review of Clinical Pharmacology 4 2011 13 32
10. L. Li, M. Bhatia, Y.Z. Zhu, Y.C. Zhu, R.D. Ramnath, and Z.J. Wang Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse FASEB Journal 19 2005 1196 1198
11. L. Rinaldi, G. Gobbi, M. Pambianco, C. Micheloni, P. Mirandola, and M. Vitale Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3 Laboratory Investigation 86 2006 391 397
12. P. Mirandola, G. Gobbi, I. Sponzilli, M. Pambianco, C. Malinverno, and A. Cacchioli Exogenous hydrogen sulfide induces functional inhibition and cell death of cytotoxic lymphocytes subsets Journal of Cellular Physiology 213 2007 826 833
13. L.F. Hu, P.T. Wong, P.K. Moore, and J.S. Bian Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia Journal of Neurochemistry 100 2007 1121 1128
14. S.K. Yan, T. Chang, H. Wang, L. Wu, R. Wang, and Q.H. Meng Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells Biochemical and Biophysical Research Communications 361 2006 485 491
15. 2S on human aorta smooth muscle cells FASEB Journal 20 2006 553 555
16. L. Zhi, A.D. Ang, H. Zhang, P.K. Moore, and M. Bhatia Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-kB pathway Journal of Leukocyte Biology 81 2007 1322 1332
17. G. Gobbi, F. Ricci, C. Malinverno, C. Carubbi, M. Pambianco, and G. Panfilis Hydrogen sulfide impairs keratinocyte cell growth and adhesion inhibiting mitogen-activated protein kinase signaling Laboratory Investigation 89 2009 994 1006
18. P. Mirandola, G. Gobbi, C. Micheloni, M. Vaccarezza, D. Di Marcantonio, and F. Ruscitti Hydrogen sulfide inhibits IL-8 expression in human keratinocytes via MAP kinase signaling Laboratory Investigation 91 2011 1188 1194
19. R. Baskar, L. Li, and P.K. Moore Hydrogen sulfide induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells FASEB Journal 21 2007 247 255
20. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocrine Reviews 18 1997 4 25
21. M.M. Cals-Grierson, and A.D. Ormerod Nitric oxide function in the skin Nitric Oxide 10 2004 179 193
22. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacological Reviews 56 2004 549 580
23. L. Li, M. Whiteman, Y.Y. Guan, K.L. Neo, Y. Cheng, and S.W. Lee Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide Circulation 117 2008 2351 2360
24. X.Y. Tian, W.T. Wong, N. Sayed, J. Luo, S.Y. Tsang, and Z.X. Bian NaHS relaxes rat cerebral artery in vitro via inhibition of l-type voltage-sensitive Ca2+ channel Pharmacological Research 65 2012 239 246
25. R.A. Dombkowski, M.J. Russell, and K.R. Olson Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 286 2004 R678 R685
26. 3 adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin Neoplasia 11 2009 1064 1073
27. 3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells Journal of Biological Chemistry 280 2005 19516 19526
28. S. Merighi, P. Mirandola, D. Milani, K. Varani, S. Gessi, and K.N. Klotz Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells Journal of Investigative Dermatology 119 2002 923 933
29. S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, and E. Leung Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells Molecular Pharmacology 72 2007 162 172
30. 2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide British Journal of Pharmacology 165 2012 1773 1788
31. S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, and E. Leung Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells Biochemical Pharmacology 72 2006 19 31
32. E.R. DeLeon, G.F. Stoy, and K.R. Olson Passive loss of hydrogen sulfide in biological experiments Analytical Biochemistry 421 2012 203 207
33. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii, and H. Kimura A source of hydrogen sulfide and a mechanism of its release in the brain Antioxidants and Redox Signalling 11 2009 205 214
34. D. Bruch-Gerharz, O. Schnorr, C. Suschek, K.F. Beck, J. Pfeilschifter, and T. Ruzicka Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation American Journal of Pathology 162 2003 203 211
35. B. Stallmeyer, H. Kämpfer, N. Kolb, J. Pfeilschifter, and S. Frank The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization Journal of Investigative Dermatology 113 1999 1090 1098
36. V. Krischel, D. Bruch-Gerharz, C. Suschek, K.D. Kröncke, T. Ruzicka, and V. Kolb-Bachofen Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts Journal of Investigative Dermatology 111 1998 286 291
37. S. Abeyakirthi, M. Mowbray, N. Bredenkamp, L. van Overloop, L. Declercq, and P.J. Davis Arginase is overactive in psoriatic skin British Journal of Dermatology 163 2010 193 196
38. E. Pipili-Synetos, E. Sakkoula, G. Haralabopoulos, P. Andriopoulou, P. Peristeris, and M.E. Maragoudakis Evidence that nitric oxide is an endogenous antiangiogenic mediator British Journal of Pharmacology 111 1994 894 902
39. E. Pipili-Synetos, E. Sakkoula, G. Haralabopoulos, P. Andriopoulou, P. Peristeris, and M.E. Maragoudakis Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate British Journal of Pharmacology 116 1995 1829 1834
40. J.A. Powell, S.N. Mohamed, J.S. Kerr, and S.A. Mousa Antiangiogenesis efficacy of nitric oxide donors Journal of Cellular Biochemistry 80 2000 104 114
41. E. Sakkoula, E. Pipili-Synetos, and M.E. Maragoudakis Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2 British Journal of Pharmacology 122 1997 793 795
42. W.J. Cai, M.J. Wang, P.K. Moore, H.M. Jin, T. Yao, and Y.C. Zhu The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation Cardiovascular Research 76 2007 29 40
43. D. Xiao, M. Li, A. Herman-Antosiewicz, J. Antosiewicz, H. Xiao, and K.L. Lew Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2 Nutrition and Cancer 55 2006 94 107
44. P. Thejass, and G. Kuttan Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by diallyl disulfide (DADS) Life Sciences 80 2007 515 521
45. M.J. Wang, W.J. Cai, N. Li, Y.J. Ding, Y. Chen, and Y.C. Zhu The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia Antioxidants and Redox Signalling 12 2010 1065 1077
46. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine 1 1995 27 31
47. M. Detmar, L.F. Brown, M.P. Schön, B.M. Elicker, P. Velasco, and L. Richard Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice Journal of Investigative Dermatology 111 1998 1 6
48. M. Detmar, L.F. Brown, K.P. Claffey, K.T. Yeo, O. Kocher, and R.W. Jackman Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis Journal of Experimental Medicine 180 1994 1141 1146
49. H.B. Schonthaler, R. Huggenberger, S.K. Wculek, M. Detmar, and E.F. Wagner Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis PNAS 106 2009 21264 21269
50. Y.P. Xia, B. Li, D. Hylton, M. Detmar, G.D. Yancopoulos, and J.S. Rudge Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis Blood 102 2003 161 168
51. C. Halin, H. Fahrngruber, J.G. Meingassner, G. Bold, A. Littlewood-Evans, and A. Stuetz Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor American Journal of Pathology 173 2008 265 277